As Ann Arbor evolves its stable of start-ups, acquisition will be the inevitable fate for more than a few. Last month Accuri Cytometers joined the list of successful exits. But how did it happen and what does it mean for the city's entrepreneurial ecosystem?
Concentrate's Jon Zemke surveys the landscape.
read on